2025
Correlation of FSTL1 and its paralogs with body composition in adult survivors of childhood cancer
ŠTRUBLOVÁ, Lucie; Filip ZLÁMAL; Tomáš PISKOVSKÝ; Jan KUČERA; Jana FIALOVÁ KUČEROVÁ et al.Základní údaje
Originální název
Correlation of FSTL1 and its paralogs with body composition in adult survivors of childhood cancer
Autoři
ŠTRUBLOVÁ, Lucie ORCID; Filip ZLÁMAL ORCID; Tomáš PISKOVSKÝ; Jan KUČERA; Jana FIALOVÁ KUČEROVÁ; Tomáš KEPÁK; Jaroslav ŠTĚRBA a Julie DOBROVOLNÁ
Vydání
Scientific Reports, Berlin, NATURE RESEARCH, 2025, 2045-2322
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Německo
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.900 v roce 2024
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/25:00141529
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
FSTL1; FSTL4; FSTL5; Adiposity; Skeletal muscle mass; Late effects; Childhood cancer survivors
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 2. 2. 2026 09:52, Mgr. Eva Suchánková
Anotace
V originále
This retrospective, cross-sectional study investigated the relationship between body composition and circulating plasma levels of follistatin-like proteins (FSTLs; FSTL1, FSTL4, and FSTL5) in adult survivors of childhood cancer. This is the first study to investigate the association between plasma levels of FSTL4, FSTL5 and skeletal muscle mass. The cohort consisted of 61 CCS (26 females and 35 males) aged 18-36 years (mean age 24.6 +/- 4.4 years) who were followed up at the Long-Term Follow-Up Clinic of St. Anne's Hospital in Brno, Czech Republic. The mean age at diagnosis was 10.9 +/- 4.9 years, and the mean time after treatment was 12.0 +/- 5.1 years. Body composition was assessed using anthropometric indicators and bioelectrical impedance analysis (BIA; InBody 370). Plasma FSTL levels were quantified using commercially available ELISA kits. Correlations were examined by linear regression analysis. A significant negative correlation was found between the FSTL1 plasma level and body fat mass index (BFMI), and a significant positive correlation was observed between FSTL1 and skeletal muscle mass index (SMI). Our results suggest that FSTL1 may be a potential indicator of adiposity and skeletal muscle loss in CCS.
Návaznosti
| MUNI/A/1370/2022, interní kód MU |
| ||
| MUNI/A/1790/2024, interní kód MU |
| ||
| 90249, velká výzkumná infrastruktura |
|